Patents by Inventor Suba Krishnan

Suba Krishnan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF CANCER WITH ANTI-GITR AGONIST ANTIBODIES
    Publication number: 20230416388
    Abstract: Provided herein are methods for treating cancer, comprising administering to a subject having cancer a therapeutically effective amount of an anti-GITR antibody alone or together with an anti-PD-1 or anti-PD-L1 antibody.
    Type: Application
    Filed: April 12, 2023
    Publication date: December 28, 2023
    Inventors: Suba KRISHNAN, Penny E. PHILLIPS, Zheng YANG, Haiqing WANG
  • Treatment of cancer with anti-GITR agonist antibodies
    Patent number: 11685787
    Abstract: Provided herein are methods for treating cancer, comprising administering to a subject having cancer a therapeutically effective amount of an anti-GITR antibody alone or together with an anti-PD-1 or anti-PD-L1 antibody.
    Type: Grant
    Filed: May 15, 2018
    Date of Patent: June 27, 2023
    Assignee: Bristol-Myers Squibb Company
    Inventors: Suba Krishnan, Penny E. Phillips, Zheng Yang, Haiqing Wang
  • TREATMENT OF CANCER WITH ANTI-GITR AGONIST ANTIBODIES
    Publication number: 20200291122
    Abstract: Provided herein are methods for treating cancer, comprising administering to a subject having cancer a therapeutically effective amount of an anti-GITR antibody alone or together with an anti-PD-1 or anti-PD-L1 antibody.
    Type: Application
    Filed: May 15, 2018
    Publication date: September 17, 2020
    Inventors: Suba KRISHNAN, Penny E. PHILLIPS, Zheng YANG, Haiqing WANG
  • TREATMENT OF CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANTI-CD137
    Publication number: 20190382491
    Abstract: This disclosure provides a method for treating a subject afflicted with a cancer, which method comprises administering to the subject therapeutically effective amounts of: (a) an antibody or an antigen-binding portion thereof that specifically binds to PD-1; and (b) an antibody or an antigen-binding portion thereof that specifically binds to CD 137.
    Type: Application
    Filed: August 1, 2019
    Publication date: December 19, 2019
    Inventors: Maria Jure-Kunkel, David M. Berman, Alan J. Korman, Mark J. Selby, Suba Krishnan
  • TREATMENT OF CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND AN ANTI-CD137 ANTIBODY
    Publication number: 20170247455
    Abstract: This disclosure provides a method for treating a subject afflicted with a cancer, which method comprises administering to the subject therapeutically effective amounts of: (a) an antibody or an antigen-binding portion thereof that specifically binds to PD-1; and (b) an antibody or an antigen-binding portion thereof that specifically binds to CD137.
    Type: Application
    Filed: August 21, 2015
    Publication date: August 31, 2017
    Inventors: Maria JURE-KUNKEL, David M. Berman, Alan J. Korman, Mark J. Selby, Suba Krishnan